Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
451.10    1.10 (0.24%)
Bid:
450.60
Ask:
450.70
Spread: 0.10 (0.022%)
Market Cap: £11.35b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

?50m Floating Rate Notes due 2013

14 Oct 2008 12:52

RNS Number : 8049F
Rentokil Initial PLC
14 October 2008
 



Rentokil Initial plc

£50m Floating Rate Notes due 2013

Rentokil Initial plc (the "Company") announces that it has entered into a commitment with an investor who will purchase £50m Floating Rate Notes due 2013 (the "FRNs"). The FRNs are expected to be issued at par under the Company's existing Euro Medium Term Note Programme and carry a coupon of LIBOR + 3.25%.  The FRNs are expected to be issued before the end of October 2008 and to be guaranteed by Rentokil Initial 1927 plc, a wholly owned subsidiary of the Company.

Rentokil Initial 1927 plc currently guarantees the obligations of the Company to its bondholders, banks and certain other financial counterparties. These guarantees were due to expire on 19 November 2008 but will now be extended to match the maturity of the Company's £300 million 5.75 per cent. Notes due 2016, issued by the Company in March 2006, and the FRNs, whichever maturity is the later.

During the last two months, Rentokil Initial has announced the issue of £125m of new debt securities (being the FRNs and the £75 million Floating Rate Reset Notes due 2033 (the "PCRs")). The Company's £250m 6.125 per cent. notes due 2008 (the "Notes") will mature on 19 November 2008 and will be repaid from the Company's bank facilities. The Company estimates that it will have at least £350m of headroom in its committed facilities after repaying the Notes.  At least £100m of that headroom is provided by a facility which is due to expire in 2012. The balance is provided by a second facility which is extendable at the Company's option to January 2010. 

After November 2008, the next maturity of the Company's bond indebtedness will be in 2013 if the holders of the PCRs exercise their right to require repayment.

For further information

Shareholder/analyst enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 020 7592 2700

Media enquiries:

Malcolm Padley, Head of Corporate Communications Rentokil Initial plc 020 7592 2700

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFUFFLSASELS
Date   Source Headline
19th Jul 20177:00 amRNSAppointment of Non-Executive Director
30th Jun 20178:33 amRNSCompletion of Joint Venture with Haniel
27th Jun 20175:21 pmRNSHolding(s) in Company
26th Jun 20174:54 pmRNSHolding(s) in Company
8th Jun 201711:40 amRNSFurther re Joint Venture with Haniel
7th Jun 20179:41 amRNSDirector Declaration
17th May 20175:02 pmRNSHolding(s) in Company
10th May 20174:31 pmRNSResult of AGM
10th May 20174:03 pmRNSHolding(s) in Company
10th May 201711:49 amRNSAppointment of Senior Independent Director
9th May 20175:51 pmRNSHolding(s) in Company
4th May 20174:44 pmRNSDirector/PDMR Shareholding
26th Apr 20174:27 pmRNSDirector/PDMR Shareholding
25th Apr 20175:58 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSRentokil awarded Queen's Award for Enterprise
19th Apr 20177:00 amRNSQ1 Trading Update
5th Apr 201710:43 amRNSAnnual Financial Report
31st Mar 20174:18 pmRNSTotal Voting Rights
30th Mar 20173:25 pmRNSBlock listing Interim Review
22nd Mar 20176:10 pmRNSHolding(s) in Company
9th Mar 20173:06 pmRNSAdditional Listing
28th Feb 20177:00 amRNSRentokil - Leading Pest Control Company in India
24th Feb 20172:37 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSFinal Results
7th Feb 20177:00 amRNSAcquisition of Allgood Pest Solutions
29th Dec 20164:30 pmRNSDirector/PDMR Shareholding
16th Dec 20162:59 pmRNSHolding(s) in Company
16th Dec 20162:02 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSJoint venture with Haniel
7th Dec 20165:47 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSHolding(s) in Company
18th Nov 20161:15 pmRNSDirector Declaration
11th Nov 20165:30 pmRNSHolding(s) in Company
11th Nov 20165:10 pmRNSTotal Voting Rights
3rd Nov 20161:01 pmRNSDirector Declaration
19th Oct 20167:00 amRNSQ3 Trading Update
6th Oct 20162:58 pmRNSAdditional Listing
6th Oct 201612:31 pmRNSDirector Declaration
4th Oct 20169:49 amRNSDirector Declaration
30th Sep 20162:10 pmRNSTotal Voting Rights
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.